Shares of West Pharmaceutical Services Inc. rose 7.84% to $214.73 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.01% to ...
West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...
It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...
On the revenue side, PBMs get paid by insurance companies to secure rebates from drugmakers in exchange for favorable ...
When done safely and securely, automated inbound engagement can provide significant benefits for pharmaceutical companies.
StockStory.org on MSN1d
West Pharmaceutical Services’s (NYSE:WST) Q4: Beats On Revenue But Stock DropsHealthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results , with sales up 2.3% year on year to $748.8 million. On the other hand, the company’s full-year revenue ...
Health system reforms to further integrate the community pharmacy sector are required to strengthen Ireland's pandemic ...
CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...
Tariffs and price inflation for specialty medications will increase costs, according to research from Vizient.
This is a commentary manuscript, which aims to carry out a critical analysis of the effects of Pharmaceutical Care (PC) without the continuity of the service by healthcare professionals. PC has proven ...
Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results